Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
EP03.01 - Epidemiology
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Epidemiology
-
+
EP03.01-009 - BrainMets-Cross-Sectional Study To Identify The Presence Of Brain Metastasis At Diagnosis Of Advanced NSCLC EGFRm in Portuguese Patients
Presenter: Maria Encarnação Teixeira- Abstract
Loading...
-
+
EP04.01 - Global Health, Health Services Research, and Health Economics - Cost Issues
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Global Health, Health Services Research, and Health Economics - Cost Issues
-
+
EP04.01-011 - Diagnostic Approach and Treatment of Lung Cancer Patients in Portugal: Portuguese Lung Cancer Study Group Survey
Presenter: Fernanda Estevinho- Abstract
Loading...
-
+
EP05.03 - Locally Advanced Non-small Cell Lung Cancer - Surgery
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Surgery
-
+
EP05.03-006 - Real-World Treatment Pathways In Stage III Non-Small Cell Lung Cancer in Portugal (PICTuRE): An Interim Analysis Of Surgical Patients
Presenter: Maria Encarnação Teixeira- Abstract
Loading...
-
+
EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
-
+
EP16.03-011 - The European Program for ROutine Testing of Patients with Advanced Lung Cancer (EPROPA) 1 Year Activity
Presenter: Francesco Passiglia- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- 14:30 - 15:30
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Moderators:Pilar Garrido, António Araújo
-
+
Session Moderator
14:32 - 00:00 | Presenter: Pilar Garrido
- Abstract
Loading... -
+
Session Moderator
14:32 - 00:00 | Presenter: António Araújo
- Abstract
Loading... -
+
OA15.01 - Session Introduction
14:30 - 14:31 | Presenter: Pilar Garrido
- Abstract
Loading... -
+
OA15.02 - Session Introduction
14:31 - 14:32 | Presenter: António Araújo
- Abstract
Loading... -
+
OA15.03 - Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+ NSCLC: Primary Analysis from JAVELIN Lung 100
14:32 - 14:42 | Presenter: Martin Reck
- Abstract
Loading... -
+
OA15.04 - Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC
14:42 - 14:52 | Presenter: Solange Peters
- Abstract
Loading... -
+
OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy
14:52 - 15:02 | Presenter: Benjamin Besse
- Abstract
Loading... -
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Presenter: Delvys Rodriguez-Abreu
- Abstract
Loading... -
+
OA15.07 - Discussant
15:12 - 15:22 | Presenter: Puey Ling Chia
- Abstract
Loading... -
+
OA15.08 - Live Q&A
15:22 - 15:30
- Abstract
Loading...